Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer

Jade S. Miller, Jeremy F. Kane, Patricia A. Ward, Marvel Shawkey, Adaline Watkins, Rachelle W. Johnson, Julie A. Rhoades

Open source

DOI
10.1016/j.jbo.2026.100752
Published
2026-04
Container
Journal of Bone Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jbo.2026.100752,
  title = {Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer},
  author = {Jade S. Miller and Jeremy F. Kane and Patricia A. Ward and Marvel Shawkey and Adaline Watkins and Rachelle W. Johnson and Julie A. Rhoades},
  year = {2026},
  journal = {Journal of Bone Oncology},
  doi = {10.1016/j.jbo.2026.100752},
  url = {https://doi.org/10.1016/j.jbo.2026.100752}
}

RIS

TY  - JOUR
TI  - Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer
AU  - Jade S. Miller
AU  - Jeremy F. Kane
AU  - Patricia A. Ward
AU  - Marvel Shawkey
AU  - Adaline Watkins
AU  - Rachelle W. Johnson
AU  - Julie A. Rhoades
PY  - 2026
JO  - Journal of Bone Oncology
DO  - 10.1016/j.jbo.2026.100752
UR  - https://doi.org/10.1016/j.jbo.2026.100752
ER  - 

APA

Miller, J. S., Kane, J. F., Ward, P. A., Shawkey, M., Watkins, A., Johnson, R. W., & Rhoades, J. A. (2026). Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer. Journal of Bone Oncology. https://doi.org/10.1016/j.jbo.2026.100752

Source records